USA: Genetic Testing Eurofins Scientific Acquires Prenatal Screening Laboratory

Editor: Alexander Stark

Eurofins Scientific, operating in the fields of bio-analytical testing and genomic services, announced that it has acquired US prenatal screening laboratory services business Perkin Elmer (NTD).

Related Vendors

Melville/US – NTD generates revenues of about US$  20 million in 2015 and has a customer basis in universities, hospitals, maternal fetal medicine specialists, and other laboratories worldwide.

"This acquisition reflects our strategy of expanding and strengthening our network of competence centers. NTD strengthens Eurofins' testing capabilities for genetic disorders, and the Group's footprint in the specialty clinical diagnostics market, with truly unique and innovative services with high positive impact for patient care. In combination with Viracor and Diatherix for infectious diseases, Boston Heart for cardiovascular, and EGL for genetic diseases, NTD's expertise in prenatal screening reinforces the Group's position in advanced diagnostic testing to better serve the global healthcare community" comments Dr. Gilles Martin, CEO Eurofins.